Esther Waschkowitz

Title: Esther Waschkowitz: Innovator in Pulmonary Drug Delivery

Introduction

Esther Waschkowitz is a prominent inventor based in Giessen, Germany. She has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative drug delivery systems. Her work focuses on enhancing the efficacy of therapeutic substances through advanced formulations.

Latest Patents

Esther Waschkowitz holds a patent for "Nebulized liposomes for the pulmonary application of drug compounds." This invention discloses a method to prepare specific liposomal formulations designed for the pulmonary application of therapeutic substances. The formulation includes liposomal components such as DPPC and cholesterol in specific molar ratios, combined with non-toxic excipients like sphingomyelin and polyethylene glycol. These liposomes are designed to be stable during nebulization and exhibit sustained release kinetics of encapsulated drug substances.

Career Highlights

Esther is currently associated with United Therapeutics Corporation, where she continues to innovate in the field of drug delivery systems. Her work has the potential to significantly improve the treatment of various pulmonary conditions through more effective drug formulations.

Collaborations

Esther collaborates with notable colleagues, including Thomas Schmehl and Tobias Gessler, who contribute to her research and development efforts.

Conclusion

Esther Waschkowitz is a trailblazer in the field of pulmonary drug delivery, with her innovative patent paving the way for advancements in therapeutic applications. Her contributions are vital to improving patient outcomes in respiratory health.